Evidence Based Medicine e-Conference

Need of Clinical Decision Support System (CDSS) for the standardization of Care

The global clinical decision support system market is expected to reach USD 1.8 billion by 2025 from an estimated USD 1.2 billion in 2020 at a CAGR of 9.1% during the forecast period. The key factors propelling the growth of this market are the implementation of government regulations and initiatives to promote the adoption of HIT solutions, increasing adoption of CDSS-enabled EHRs, increasing number of collaborations and partnerships between stakeholders, growing incidence of medication errors, and the rising prominence of mHealth and big data tools. However, the high investment requirements for the implementation of CDSS and the lack of interoperability and data security concerns are expected to restrain the growth of this market during the forecast period.

Geographically, the clinical decision support system s market is segmented into North America, Europe, Asia Pacific (APAC), and the Rest of the World. The market in the APAC is expected to grow at the highest CAGR over the next five years. Factors such as the presence of a large geriatric population, improved government legislation, high burden of chronic diseases, and the growing focus of various market players on emerging Asian countries are expected to drive the growth of the CDSS market in Asia.

Highlights:

COVID-19 Impact on the Clinical decision support system Market

Clinical Decision Support System Market Dynamics

Drivers: Growing incidence of medication error

Restrains: Data security concerns related to cloud based CDSS

Opportunities: Emerging Asian countries

Knowledge-based CDSS can provide reasoning in the face of uncertainties which is often required of CDSS solutions

Rising need to control the cost of healthcare to drive the demand for CDSS in ambulatory care settings

Asia Pacific to witness significant growth from 2020 to 2025